Phuong N. Huynh

Array ( [id] => 5642292 [patent_doc_number] => 20060280747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 11/342249 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 52797 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280747.pdf [firstpage_image] =>[orig_patent_app_number] => 11342249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666568 [patent_doc_number] => 20060171918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Apoptosis inducing molecule I' [patent_app_type] => utility [patent_app_number] => 11/337690 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19751 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171918.pdf [firstpage_image] =>[orig_patent_app_number] => 11337690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666998 [patent_doc_number] => 20060172348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Use of neuronal apoptosis inhibitor protein (NAIP)' [patent_app_type] => utility [patent_app_number] => 11/329884 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 18254 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172348.pdf [firstpage_image] =>[orig_patent_app_number] => 11329884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461453 [patent_doc_number] => 07879977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Methods and reagents for decreasing clinical reaction to allergy' [patent_app_type] => utility [patent_app_number] => 11/329924 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8872 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 699 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879977.pdf [firstpage_image] =>[orig_patent_app_number] => 11329924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699599 [patent_doc_number] => 20060216283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Inhibition of secretion from non-neuronal cells' [patent_app_type] => utility [patent_app_number] => 11/327855 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12907 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216283.pdf [firstpage_image] =>[orig_patent_app_number] => 11327855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530980 [patent_doc_number] => 07871611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Compositions and methods relating to anti IGF-1 receptor antibodies' [patent_app_type] => utility [patent_app_number] => 11/313209 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 43 [patent_no_of_words] => 46787 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871611.pdf [firstpage_image] =>[orig_patent_app_number] => 11313209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867468 [patent_doc_number] => 07364729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Method of inducing a CTL response' [patent_app_type] => utility [patent_app_number] => 11/313152 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 26475 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364729.pdf [firstpage_image] =>[orig_patent_app_number] => 11313152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648379 [patent_doc_number] => 20060134111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy' [patent_app_type] => utility [patent_app_number] => 11/303811 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17730 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134111.pdf [firstpage_image] =>[orig_patent_app_number] => 11303811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 468155 [patent_doc_number] => 07232570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-19 [patent_title] => 'ERAAP modulators regulate immune responses' [patent_app_type] => utility [patent_app_number] => 11/300169 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5391 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/232/07232570.pdf [firstpage_image] =>[orig_patent_app_number] => 11300169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742805 [patent_doc_number] => 20060088530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Photodynamic therapy treatment for eye disease' [patent_app_type] => utility [patent_app_number] => 11/297880 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5694 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088530.pdf [firstpage_image] =>[orig_patent_app_number] => 11297880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5660984 [patent_doc_number] => 20060251580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Lectin conjugates' [patent_app_type] => utility [patent_app_number] => 11/294963 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7548 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251580.pdf [firstpage_image] =>[orig_patent_app_number] => 11294963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693735 [patent_doc_number] => 20060153882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound' [patent_app_type] => utility [patent_app_number] => 11/294845 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4059 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153882.pdf [firstpage_image] =>[orig_patent_app_number] => 11294845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6411259 [patent_doc_number] => 20100166654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Single-Drug Multi-Ligand Conjugates for Targeted Drug Delivery' [patent_app_type] => utility [patent_app_number] => 11/792329 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9329 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166654.pdf [firstpage_image] =>[orig_patent_app_number] => 11792329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514228 [patent_doc_number] => 20090214534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY' [patent_app_type] => utility [patent_app_number] => 11/791930 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 45168 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214534.pdf [firstpage_image] =>[orig_patent_app_number] => 11791930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948918 [patent_doc_number] => 20080305044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Engineered Antibodies and Immunoconjugates' [patent_app_type] => utility [patent_app_number] => 11/720244 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22949 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305044.pdf [firstpage_image] =>[orig_patent_app_number] => 11720244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518495 [patent_doc_number] => 07972596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Antibodies against vascular endothelial growth factor receptor-1' [patent_app_type] => utility [patent_app_number] => 11/719677 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 55 [patent_no_of_words] => 15603 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972596.pdf [firstpage_image] =>[orig_patent_app_number] => 11719677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682961 [patent_doc_number] => 20060199231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Detection of activation of endothelial cells as surrogate marker for angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/267870 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 36908 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199231.pdf [firstpage_image] =>[orig_patent_app_number] => 11267870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631539 [patent_doc_number] => 20060148009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Prediction and assessment of immunogenicity' [patent_app_type] => utility [patent_app_number] => 11/249692 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 28125 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148009.pdf [firstpage_image] =>[orig_patent_app_number] => 11249692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171323 [patent_doc_number] => 20070071754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Method to ameliorate inflammation' [patent_app_type] => utility [patent_app_number] => 11/234970 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4749 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071754.pdf [firstpage_image] =>[orig_patent_app_number] => 11234970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584714 [patent_doc_number] => 07438906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics' [patent_app_type] => utility [patent_app_number] => 11/230462 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20536 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/438/07438906.pdf [firstpage_image] =>[orig_patent_app_number] => 11230462 [rel_patent_id] =>[rel_patent_doc_number] =>)